The calcar bone graft.
A canine model was developed to investigate the use of an autogeneic iliac bone graft to treat the calcar deficiency commonly found at the time of revision surgery for femoral component loosening. Five large male mixed-breed dogs had bilateral total hip arthroplasty staged at three-month intervals, and were sacrificed at six months. Prior to cementing the femoral component, an experimental calcar defect was made, and a bicortical iliac bone graft was fashioned to fill the defect. Serial roentgenograms showed the grafts had united with no resorption. Technetium-99 bone scans showed more uptake at three months than at six months in the graft region. Disulfine blue injection indicated all grafts were perfused at both three and six months. Thin section histology, fluorochromes, and microradiographs confirmed graft viability in all dogs. Semiquantitative grading of the fluorochromes indicated new bone deposition in 20%-50% of each graft at three months and 50%-80% at six months. Although the calcar bone graft was uniformly successful in this canine study, the clinical application of this technique should be evaluated by long-term results in humans.
D000818:Animals; D001846:Bone Development; D001862:Bone Resorption; D016025:Bone Transplantation; D004195:Disease Models, Animal; D004285:Dogs; D005269:Femur / Q000000981:diagnostic imaging / Q000601:surgery*; D005456:Fluorescent Dyes; D006622:Hip Prosthesis; D006801:Humans; D007085:Ilium / Q000637:transplantation; D008297:Male; D008852:Microradiography; D011877:Radionuclide Imaging; D013667:Technetium; D014182:Transplantation, Autologous
D005456:Fluorescent Dyes; D013667:Technetium